Sam Chun Dang Pharm Co Ltd banner
S

Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250

Watchlist Manager
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Watchlist
Price: 825 000 KRW 8.98%
Market Cap: ₩19.4T

Balance Sheet

Balance Sheet Decomposition
Sam Chun Dang Pharm Co Ltd

Balance Sheet
Sam Chun Dang Pharm Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
9 216
6 236
33 943
33 089
34 862
48 622
61 907
51 471
60 273
58 935
2 028
14
40 427
105 585
Cash
0
464
519
694
314
653
792
858
82
53
28
14
37 427
99 585
Cash Equivalents
9 216
5 772
33 424
32 395
34 548
47 969
61 115
50 613
60 191
58 882
2 000
0
3 000
6 000
Short-Term Investments
10 000
5 333
5 546
9 769
13 236
9 571
7 370
30 578
39 436
38 031
47 912
64 148
52 317
29 332
Total Receivables
29 327
28 699
30 883
33 944
32 687
38 618
39 065
37 082
38 900
36 540
38 589
39 004
35 111
61 387
Accounts Receivables
22 546
24 618
26 464
28 121
27 404
31 175
31 654
30 684
30 248
26 979
32 194
35 461
31 080
35 912
Other Receivables
6 781
4 081
4 419
5 823
5 283
7 443
7 411
6 398
8 652
9 561
6 395
3 543
4 031
25 475
Inventory
13 005
15 572
15 931
16 974
17 738
19 171
21 849
22 430
23 035
25 336
27 908
31 913
35 263
38 191
Other Current Assets
105
727
451
396
423
622
1 018
711
848
7 685
5 398
584
788
8 038
Total Current Assets
61 652
56 567
86 754
94 172
98 946
116 603
131 208
142 272
162 493
166 528
168 920
157 749
163 906
242 532
PP&E Net
26 803
49 666
49 639
54 589
59 307
57 928
55 175
60 727
57 334
63 276
74 112
87 212
90 009
103 595
PP&E Gross
26 803
49 666
49 639
54 589
59 307
57 928
55 175
60 727
57 334
63 276
74 112
87 212
90 009
103 595
Accumulated Depreciation
17 912
22 567
25 278
28 889
26 640
29 867
35 657
41 235
46 724
46 898
52 158
58 835
66 596
74 001
Intangible Assets
1 623
1 658
1 416
3 125
4 822
9 321
11 290
17 312
26 480
29 124
44 685
77 095
92 556
118 441
Goodwill
0
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
Note Receivable
0
0
0
0
0
0
0
1 000
0
0
38
2 961
4 723
3 902
Long-Term Investments
7 261
8 722
11 545
14 590
15 656
15 685
26 859
33 694
34 466
50 951
40 311
34 601
33 660
31 198
Other Long-Term Assets
1 191
1 721
2 279
2 270
1 785
1 831
1 867
2 409
5 632
3 455
14 186
9 430
19 423
16 359
Other Assets
0
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
3 745
Total Assets
98 530
N/A
122 079
+24%
155 379
+27%
172 491
+11%
184 260
+7%
205 113
+11%
230 143
+12%
261 158
+13%
290 151
+11%
317 079
+9%
345 997
+9%
372 793
+8%
408 022
+9%
519 772
+27%
Liabilities
Accounts Payable
2 932
4 205
3 302
7 320
4 770
3 828
4 435
3 393
3 617
3 178
4 758
4 943
3 862
4 848
Accrued Liabilities
834
1 719
2 680
3 766
4 076
4 675
5 717
9 558
10 295
6 448
8 328
10 865
11 428
15 688
Short-Term Debt
0
7 643
3 318
3 434
4 631
6 979
2 336
2 212
2 439
2 011
1 580
2 756
12 226
12 290
Current Portion of Long-Term Debt
0
3 771
12 506
1 700
0
0
0
10 766
11 840
915
20 714
1 330
21 470
17 536
Other Current Liabilities
5 995
6 887
7 980
10 327
8 236
10 665
11 211
12 490
17 014
11 106
18 701
18 265
8 971
43 059
Total Current Liabilities
9 761
24 225
29 786
26 548
21 714
26 147
23 699
38 419
45 206
23 658
54 081
38 160
57 957
93 421
Long-Term Debt
0
6 441
1 374
0
0
0
3 000
7 177
9 573
24 149
29 248
72 505
19 929
20 115
Deferred Income Tax
1 139
1 385
1 482
1 081
666
310
1 753
0
0
0
0
0
0
0
Minority Interest
0
4 492
26 109
34 236
39 998
45 837
52 417
57 245
65 325
71 070
76 206
71 901
77 961
83 299
Other Liabilities
3 539
3 394
3 505
5 186
7 565
7 654
7 934
9 799
12 175
11 576
12 367
16 487
31 676
56 832
Total Liabilities
14 438
N/A
39 937
+177%
62 256
+56%
67 050
+8%
69 944
+4%
79 947
+14%
88 804
+11%
112 640
+27%
132 279
+17%
130 453
-1%
171 902
+32%
199 052
+16%
187 523
-6%
253 667
+35%
Equity
Common Stock
10 000
10 000
10 000
10 526
10 619
11 000
11 053
11 053
11 053
11 384
11 384
11 384
11 729
11 729
Retained Earnings
63 742
64 234
71 750
80 797
89 093
97 175
106 081
120 001
128 793
126 987
112 514
112 079
106 015
95 452
Additional Paid In Capital
8 775
8 775
9 923
12 826
13 302
15 825
16 596
16 596
16 596
46 911
46 911
47 283
99 640
99 846
Unrealized Security Profit/Loss
350
174
224
65
78
59
6 385
356
206
223
1 937
1 378
1 451
680
Treasury Stock
1 988
1 988
1 988
1 988
1 988
1 988
1 988
1 988
1 988
1 988
1 988
1 988
1 988
568
Other Equity
3 213
947
3 213
3 213
3 213
3 213
3 213
3 213
3 213
3 109
3 336
3 606
3 651
58 966
Total Equity
84 092
N/A
82 142
-2%
93 123
+13%
105 440
+13%
114 317
+8%
125 166
+9%
141 339
+13%
148 518
+5%
157 872
+6%
186 626
+18%
174 095
-7%
173 741
0%
220 499
+27%
266 105
+21%
Total Liabilities & Equity
98 530
N/A
122 079
+24%
155 379
+27%
172 491
+11%
184 260
+7%
205 113
+11%
230 143
+12%
261 158
+13%
290 151
+11%
317 079
+9%
345 997
+9%
372 793
+8%
408 022
+9%
519 772
+27%
Shares Outstanding
Common Shares Outstanding
19
19
19
20
21
21
21
21
21
22
22
22
23
23
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett